The latest closing stock price for Xilio Therapeutics as of September 18, 2024 is 0.81.
An investor who bought $1,000 worth of Xilio Therapeutics stock at the IPO in 2021 would have $-949 today, roughly -1 times their original investment - a -62.94% compound annual growth rate over 3 years.
The all-time high Xilio Therapeutics stock closing price was 25.11 on November 16, 2021.
The Xilio Therapeutics 52-week high stock price is 2.89, which is 256.8% above the current share price.
The Xilio Therapeutics 52-week low stock price is 0.49, which is 39.5% below the current share price.
The average Xilio Therapeutics stock price for the last 52 weeks is 1.06.
An investor who bought $1,000 worth of Xilio Therapeutics stock at the IPO in 2021 would have $-949 today, roughly -1 times their original investment - a -62.94% compound annual growth rate over 3 years.
The all-time high Xilio Therapeutics stock closing price was 25.11 on November 16, 2021.
The Xilio Therapeutics 52-week high stock price is 2.89, which is 256.8% above the current share price.
The Xilio Therapeutics 52-week low stock price is 0.49, which is 39.5% below the current share price.
The average Xilio Therapeutics stock price for the last 52 weeks is 1.06.